Bellerophon Therapeutics, Inc. Total Assets
Bellerophon Therapeutics, Inc. had Total Assets of $4.98 million as of 2023-09-30, per its 10-Q filed 2023-11-14.
Discontinued › Balance Sheet › Assets
us-gaap:Assets · last filed 2023-11-14
- 2023-09-30: Assets $4.98M.
- 2023-06-30: Assets $11.24M.
- 2023-03-31: Assets $15.97M.
- 2022-12-31: Assets $7.93M.
| Period end | Assets |
|---|---|
| 2023-09-30 | $4.98M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $11.24M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $15.97M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $7.93M 10-Q · filed 2023-11-14 |
| 2022-09-30 | $12.61M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $17.73M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $21.75M 10-Q · filed 2022-05-11 |
| 2021-12-31 | $26.88M 10-K · filed 2023-03-31 |
| 2021-09-30 | $31.32M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $37.08M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $42.19M 10-Q · filed 2021-05-11 |
| 2020-12-31 | $50.24M 10-K · filed 2022-03-31 |
| 2020-09-30 | $57.04M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $62.65M 10-Q · filed 2020-08-05 |
| 2020-03-31 | $11.58M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $13.11M 10-K · filed 2021-03-11 |
| 2019-09-30 | $16.61M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $20.58M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $24.79M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $18.36M 10-K · filed 2020-04-06 |
| 2018-09-30 | $23.64M 10-Q · filed 2018-11-07 |
| 2018-06-30 | $29.82M 10-Q · filed 2018-08-01 |
| 2018-03-31 | $35.89M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $36.81M 10-K · filed 2019-03-14 |
| 2017-09-30 | $40.87M 10-Q · filed 2017-11-07 |
| 2017-06-30 | $22.36M 10-Q · filed 2017-08-07 |
| 2017-03-31 | $25.76M 10-Q · filed 2017-05-15 |
| 2016-12-31 | $29.70M 10-K · filed 2018-03-15 |
| 2016-09-30 | $22.78M 10-Q · filed 2016-11-08 |
| 2016-06-30 | $26.28M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $31.22M 10-Q · filed 2016-05-10 |
| 2015-12-31 | $38.41M 10-K · filed 2017-03-13 |
| 2015-09-30 | $49.16M 10-Q · filed 2015-11-12 |
| 2015-06-30 | $62.37M 10-Q · filed 2015-08-14 |
| 2015-03-31 | $75.18M 10-Q · filed 2015-05-15 |
| 2014-12-31 | $33.39M 10-K · filed 2016-03-21 |